Indivior Pharmaceuticals, Inc 6-K, filed Dec 23, 2024
Indivior Pharmaceuticals, Inc. (INDV)
6-K
2024-12-23
For: 2024-12-23
View Original
Added on
April 10, 2026
About this 6-K
Indivior Pharmaceuticals, Inc filed this 6-K on December 23, 2024.
|
|
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
________________________
Washington, D.C. 20549
_____________________
FORM 6-K
_____________________
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16
under the Securities Exchange Act of 1934
For the month of December 2024
Commission File Number: 001-37835
________________________________________
Indivior PLC
________________________________________
10710 Midlothian Turnpike, Suite 125
North Chesterfield, Virginia 23235
(Address of principal executive office)
_______________________________
Indicate
by check mark whether the registrant files or will file annual
reports under cover of Form 20-F or Form 40-F
Form
20-F ☒ Form 40-F ☐
|
|
EXHIBIT INDEX
|
Exhibit No.
|
Description of Exhibit
|
|
99.1
|
|
|
|
|
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf
by the undersigned, thereunto duly authorized.
|
|
Indivior PLC
|
|
Date: December 23, 2024
|
/s/
Kathryn Hudson
|
|
|
Name:
Kathryn Hudson
|
|
|
Title:
Company Secretary
|
Exhibit 99.1
INDIVIOR PLC (THE 'COMPANY')
NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS
DISCHARGING MANAGERIAL RESPONSIBILITIES ('PDMR') AND PERSONS
CLOSELY ASSOCIATED WITH THEM
The Company announces that it received notification on December 20,
2024 that Robert Schriesheim, a Non-Executive Director of the
Company, acquired a total of 21,400 Ordinary Shares of
US$0.50 each in the Company ('Shares') at an average price of
$11.73 per share on December 20, 2024.
Following this transaction, Robert Schriesheim has an interest in
21,400 shares in the Company.
|
1
|
Details of the person discharging managerial responsibilities /
person closely associated
|
|
|
a)
|
Name
|
Robert A. Schriesheim
|
|
2
|
Reason for the notification
|
|
|
a)
|
Position/status
|
Non-Executive Director / PDMR
|
|
b)
|
Initial notification /Amendment
|
Initial notification
|
|
3
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
|
|
|
a)
|
Name
|
Indivior PLC
|
|
b)
|
LEI
|
213800V3NCQTY7IED471
|
|
4
|
Details of the transaction(s): section to be repeated for (i) each
type of instrument; (ii) each type of transaction; (iii) each date;
and (iv) each place where transactions have been
conducted
|
|
|
a)
|
Description of the financial instrument, type of
instrument
Identification code
|
Ordinary Shares of US$0.50
GB00BN4HT335
|
|
b)
|
Nature of the transaction
|
Purchase of Shares
|
|
c)
|
Price(s) and volume(s)
|
Price(s)Volume(s)$11.7321,400
|
|
d)
|
Aggregated information
- Aggregated volume
- Price
|
N/A
|
|
e)
|
Date of the transaction
|
December 20, 2024
|
|
f)
|
Place of the transaction
|
Nasdaq Global Select Market
|